PHENYLBUTAZONE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for phenylbutazone and what is the scope of patent protection?
Phenylbutazone
is the generic ingredient in three branded drugs marketed by Sanofi Aventis Us, Novartis, Fosun Pharma, Ivax Pharms, Sun Pharm Industries, and Watson Labs, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.There are nine drug master file entries for phenylbutazone.
Summary for PHENYLBUTAZONE
US Patents: | 0 |
Tradenames: | 3 |
Applicants: | 6 |
NDAs: | 11 |
Drug Master File Entries: | 9 |
Raw Ingredient (Bulk) Api Vendors: | 118 |
Clinical Trials: | 1 |
Patent Applications: | 6,805 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PHENYLBUTAZONE at DailyMed |
Recent Clinical Trials for PHENYLBUTAZONE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Federal University of São Paulo | Phase 4 |
Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |